Fibromyalgia Health Outcome Study on Cost of Treatments
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments
(REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in
approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to
examine treatment patterns and health outcomes of adult participants diagnosed by their
physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent" for FM.
The primary benefit of this study is enhanced understanding of the disease state of FM and
the role that pharmacologic treatment plays, which may help to optimize management of FM.
This study will address current gaps in a rapidly growing body of literature on FM.